Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-25 @ 8:49 PM
Study NCT ID:
NCT01349569
Status:
COMPLETED
Last Update Posted:
2019-01-15
First Post:
2011-05-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-01
Start Date Type:
None
Primary Completion Date:
2016-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-05
First Submit QC Date:
None
Study First Post Date:
2011-05-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-11-29
Results First Submit QC Date:
None
Results First Post Date:
2019-01-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-14
Last Update Post Date:
2019-01-15
Last Update Post Date Type:
ACTUAL